Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research Snapshot

One-page overview of trials, participants, papers, and research networks.

Clinical Guidelines

Trial-anchored manuals and protocol guidance with competency mapping.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
Media, Education & EngagementEducational Platforms & ResourcesOnline Resources
Media, Education & Engagement
Media, Education & EngagementEducational Platforms & Resources

Ohio State University

United States
5 Trials

The Ohio State University is a public land-grant research university based in Columbus, Ohio, offering undergraduate, graduate, and professional programs and conducting research across many fields. It was founded as the Ohio Agricultural and Mechanical College and serves as a major educational and economic institution in Ohio.

Quick Facts

Type
academic
Founded
1870
HQ
United States
Website
Visit

Sponsored Trials

4
Not yet recruitingII

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants with Depression and Anxiety

Start Date
March 1, 2025
Compounds
Psilocybin, Placebo
Active not recruitingII

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Start Date
January 1, 2023
Compounds
Psilocybin
Active not recruitingIV

Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study

Start Date
March 30, 2022
Compounds
Ketamine
CompletedI

Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural Product

Start Date
October 9, 2019

Collaborated Trials

1
WithdrawnII

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

Start Date
May 1, 2026
Compounds
Placebo, Psilocybin

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.